Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TAM”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00210028
What this trial is testing

Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Institut Claudius Regaud 40
Testing effectiveness (Phase 2)Ended earlyNCT04570956
What this trial is testing

Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk

Who this might be right for
Breast Atypical HyperplasiaBreast Lobular Carcinoma in SituBreast Atypical Lobular Hyperplasia+1 more
Mayo Clinic 65
Not applicableStudy completedNCT07023055
What this trial is testing

Serum TAM Receptor Tyrosine Kinase Ligands in Acute Pancreatitis

Who this might be right for
Acute Pancreatic NecrosisAcute Pancreatitis (AP)
Peking Union Medical College Hospital 896
Testing effectiveness (Phase 2)Study completedNCT00253539
What this trial is testing

Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer

Who this might be right for
Breast CancerHereditary Breast/Ovarian Cancer (brca1, brca2)
The Cleveland Clinic 3
Large-scale testing (Phase 3)Study completedNCT00003857
What this trial is testing

Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ

Who this might be right for
Breast Cancer
Radiation Therapy Oncology Group 636
Testing effectiveness (Phase 2)Ended earlyNCT03176277
What this trial is testing

ONO-7475 in Patients With Acute Leukemias

Who this might be right for
Acute LeukemiaMyelodysplastic Syndromes
Ono Pharmaceutical Co., Ltd. 42
Early research (Phase 1)Ended earlyNCT04458259
What this trial is testing

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

Who this might be right for
Neoplasm Metastasis
Pfizer 88
Large-scale testing (Phase 3)Study completedNCT00002777
What this trial is testing

Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 342
Large-scale testing (Phase 3)Study completedNCT00605267
What this trial is testing

Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment

Who this might be right for
Breast Cancer
AstraZeneca 197
Large-scale testing (Phase 3)Study completedNCT00002644
What this trial is testing

Tamoxifen for the Prevention of Breast Cancer in High-Risk Women

Who this might be right for
Breast Cancer
Queen Mary University of London 7,154
Not applicableStudy completedNCT01050634
What this trial is testing

Sequencing Of Endocrine Therapy In Post-Menopausal Women With Early Breast Cancer (FAST)

Who this might be right for
Post Menopausal Women With Early Breast Cancer
Pfizer 980
Early research (Phase 1)Ended earlyNCT02936206
What this trial is testing

Examination of Breast Cancer Cells of Pre-menopausal and Post-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant.

Who this might be right for
Breast Cancer
Icahn School of Medicine at Mount Sinai 2
Large-scale testing (Phase 3)UnknownNCT00003016
What this trial is testing

Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer

Who this might be right for
Breast Cancer
University of Oxford 20,000
Not applicableStudy completedNCT01075802
What this trial is testing

Study of Tamoxifen Dose Escalation in Breast Cancer Patients With CYP2D6 Polymorphisms

Who this might be right for
Breast CancerCYP2D6 Polymorphism
Western Sydney Local Health District 121
Testing effectiveness (Phase 2)Study completedNCT05378269
What this trial is testing

Study of Intravaginal Tamoxifen in PostMenopausal Women With VVA

Who this might be right for
Vulvar Atrophy
Daré Bioscience, Inc. 17
Not applicableEnded earlyNCT06660030
What this trial is testing

Factors Influencing Tamoxifen Adherence in Women With Breast Cancer Receiving Tamoxifen in Botswana.

Who this might be right for
Breast Cancer Female
University of Pennsylvania 10
Testing effectiveness (Phase 2)Study completedNCT00764322
What this trial is testing

Studying Blood Samples From Women With Breast Cancer or Ductal Carcinoma In Situ Who Are Receiving Tamoxifen

Who this might be right for
Breast CancerMenopausal Symptoms
UNC Lineberger Comprehensive Cancer Center 501
Not applicableStudy completedNCT02979301
What this trial is testing

Impact of Low-dose Tamoxifen on BPU

Who this might be right for
High Background Uptake on MBI
Mayo Clinic 22
Not applicableUnknownNCT03582865
What this trial is testing

Genetic Study of CYP2D6 Enzyme and Therapeutic Drug Monitoring of Tamoxifen

Who this might be right for
Breast Cancer
Assiut University 100
Post-approval studies (Phase 4)Ended earlyNCT02819921
What this trial is testing

Desvenlafaxine for Treatment of Hot Flashes in Women With Breast Cancer Taking Tamoxifen

Who this might be right for
Hot FlashesBreast Neoplasms
Seoul National University Hospital 59
Next Page